← Evidence map

ReviewCancers2025

Modern Management of the Axilla in HER2-Negative Hormone Receptor-Positive Early Breast Cancer Upfront Surgery: Toward De-Escalation and Individualization.

Halima Abahssain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Modern Management of the Axilla in HER2-Negative Hormone Receptor-Positive Early Breast Cancer Upfront Surgery: Toward De-Escalation and Individualization. | OpenQuestion